Global Bioreactors Market

Bioreactors Market Size, Share, Growth Analysis, By Materials (Glass, Stainless Steel), By Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), By Control Type (Manual, and Automated) By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2293 | Region: Global | Published Date: November, 2024
Pages: 177 | Tables: 144 | Figures: 72

Bioreactors Market Insights

Global Bioreactors Market size was valued at around USD 1.35 million in 2022 and is expected to rise from USD 1.46 million in 2023 to reach a value of USD 2.68 million by 2031, at a CAGR of 7.9% over the forecast period (2024–2031).

The use of bioreactors in the pharmaceutical sector is increasing driving bioreactors market growth. Bioreactors are vital for the development and improvement of various procedures due to which they are mostly used in pharmaceutical and biopharmaceutical research. Many industrial procedures also require bioreactors to use as subjects or for cultivating various organisms utilized for treating chronic illnesses. However, most pharmaceutical products use bioreactors in controlled conditions. Furthermore, the demand for monoclonal antibiotics is also increasing rapidly, contributing to the growth of the bioreactors market. Government bodies are also investing in funds along with private organizations to increase the production of various vaccines for different diseases. There is also subsequent demand for single-use bioreactors, which is also generating a large amount of revenue and expanding the bioreactors market. The pharma and biotechnology sectors are advancing and increasing, contributing to the growth of the bioreactors market. Technological innovation is also playing a vital part in the utilization of advanced bioreactors and different equipment of innovative features.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Bioreactors Market size was valued at around USD 1.35 million in 2022 and is expected to rise from USD 1.46 million in 2023 to reach a value of USD 2.68 million by 2031, at a CAGR of 7.9% over the forecast period (2024–2031).

The bioreactor market is extremely competitive in nature due to the combination of prominent global and smaller and medium-sized companies. These organizations are all striving to increase their market share. Companies are also constantly focusing on innovations like automation and process control, integrated sensors and analytics, high-density cell cultures, and hybrid bioreactors. Furthermore, the market leaders are efficiently leading this dynamic setting with advancements through massive investments in research and development. Focus on strategic alliances, acquisitions, and mergers are also playing a vital part in the growth of the bioreactors market. 'Sartorius AG (Germany) ', 'Thermo Fisher Scientific Inc. (U.S.) ', 'General Electric (U.S.) ', 'Eppendorf AG (Germany) ', 'Merck KGaA (Germany) ', 'Pall Corporation (U.S.) ', 'ZETA (India) ', 'PRaj Hipurity Systems Limited (India) ', 'Bioengineering AG (Switzerland) ', 'Infors AG (Switzerland) ', 'Solaris Biotechnology Srl. (Donaldson Company) (Italy) ', 'Bbi Biotech (Germany) ', 'Shanghai Bailun Biotechnology co., Ltd. (China) ', 'PBS Biotech Inc. (U.S.) ', 'CerCell A/S (Denmark) ', 'GEA Group Aktiengesellschaft (Germany) ', 'M+W Group (Germany) ', 'Technip S.A. (France) ', 'Jacobs Engineering Group Inc. (U.S.)'

For manufacturing various kinds of vaccines that plays an important part in mitigative several diseases are driving the growth of the market. Lately, the outbreak of COVID-19 pandemic increased the demand for COVID vaccines, resulting in high requirement for bioreactors of the clinical stage. In such situations, bioreactors are massively adopted in different pharmaceutical companies to successfully introduce preventive vaccines in the market.

Increasing Technological Development: Continuous Innovations in the characteristics of the bioreactors and the processing of bioreactors are propelling market growth. Active involvement of manufacturers in creating advanced technology will offer cost-efficient bioreactors and assist in the production of massive amount of items. This is increasing the growth of the bioreactors market. There are also various advantages of using advanced bioreactors and these will help in generating more revenue in the market.

North America is dominating the bioreactors market with maximum market revenue. This dramatic surge in the market is mainly due to the presence of well-known manufacturers leading the market in the region. Moreover, there is also an increase in the number of patients suffering from chronic diseases along with the growth in geriatric population. These are increasing the demand for bioreactors in the market. Private and public facilities are also making massive investment in research and development activities for introducing new and advanced products, driving the growth of the market. The facilities offered for conducting research and development have advanced infrastructure to smoothen complex research activities. This research is also being supported by government as the demand for different types of vaccines have increased. These are propelling the growth of bioreactors market in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Bioreactors Market

Report ID: SQMIG35H2293

$5,300
BUY NOW GET FREE SAMPLE